Translational errors: From yeast to new therapeutic targets

FEMS Yeast Research

Volumn 10, Issue 8, 2010, Pages 1070-1082

  Bidou, Laure ^a,b,c   Rousset, Jean Pierre ^a,b   Namy, Olivier ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Aminoglycosides; Frameshifting; Genetic diseases; HIV 1; Stop codon readthrough; Yeast

Indexed keywords

EFAVIRENZ; ENFUVIRTIDE; INDINAVIR; MARAVIROC; MESSENGER RNA; RALTEGRAVIR; TRANSFER RNA; TRANSLATION TERMINATION FACTOR; VIRUS RNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CODON; DRUG BINDING; GENE INACTIVATION; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REVERSE TRANSCRIPTION; REVIEW; RIBOSOMAL FRAMESHIFTING; RNA TRANSCRIPTION; RNA TRANSLATION; SACCHAROMYCES CEREVISIAE; SARS CORONAVIRUS; VIRUS REPLICATION; YEAST;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1; SACCHAROMYCES CEREVISIAE;

EID: 78349241066     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2010.00684.x     Document Type: Review

References (118)

1. Allamand V, Bidou L, Arakawa M et al. (2008) Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes. J Gene Med 10: 217-224.
2. Allmang C & Krol A (2006) Selenoprotein synthesis: UGA does not end the story. Biochimie 88: 1561-1571.
3. Arakawa M, Shiozuka M, Nakayama Y et al. (2003) Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice. J Biochem 134: 751-758.
4. Asakura T, Sasaki T, Nagano F et al. (1998) Isolation and characterization of a novel actin filament-binding protein from Saccharomyces cerevisiae. Oncogene 16: 121-130.
5. Atkins JF, Wills NM, Loughran G et al. (2007) A case for "StopGo": reprogramming translation to augment codon meaning of GGN by promoting unconventional termination (Stop) after addition of glycine and then allowing continued translation (Go). RNA 13: 803-810.
6. Auld DS, Thorne N, Maguire WF & Inglese J (2009) Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. P Natl Acad Sci USA 106: 3585-3590.
7. Auld DS, Lovell S, Thorne N et al. (2010) Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. P Natl Acad Sci USA 107: 4878-4883.
8. Aupeix-Scheidler K, Chabas S, Bidou L, Rousset JP, Leng M & Toulme JJ (2000) Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo(2'-O-methylribonucleotide) directed against the HIV-1 gag-pol frameshift signal. Nucleic Acids Res 28: 438-445.
9. Bach S, Talarek N, Andrieu T et al. (2003) Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol 21: 1075-1081.
10. Baranov PV, Gesteland RF & Atkins JF (2002) Recoding: translational bifurcations in gene expression. Gene 286: 187-201.
11. Baranov PV, Henderson CM, Anderson CB, Gesteland RF, Atkins JF & Howard MT (2005) Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology 332: 498-510.
12. Baranov PV, Fayet O, Hendrix RW & Atkins JF (2006) Recoding in bacteriophages and bacterial IS elements. Trends Genet 22: 174-181.
13. Baril M, Dulude D, Gendron K, Lemay G & Brakier-Gingras L (2003) Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M. RNA 9: 1246-1253.
14. Barrell BG, Bankier AT & Drouin J (1979) A different genetic code in human mitochondria. Nature 282: 189-194.
15. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE & Sweeney HL (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104: 375-381.
16. Bedwell DM, Kaenjak A, Benos DJ et al. (1997) Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med 3: 1280-1284.
17. Bertrand C, Prere MF, Gesteland RF, Atkins JF & Fayet O (2002) Influence of the stacking potential of the base 3' of tandem shift codons on -1 ribosomal frameshifting used for gene expression. RNA 8: 16-28.
18. Bidou L, Stahl G, Grima B, Liu H, Cassan M & Rousset JP (1997) In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal. RNA 3: 1153-1158.
19. Bidou L, Stahl G, Hatin I, Namy O, Rousset JP & Farabaugh PJ (2000) Nonsense-mediated decay mutants do not affect programmed -1 frameshifting. RNA 6: 952-961.
20. Bidou L, Hatin I, Perez N, Allamand V, Panthier JJ & Rousset JP (2004) Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. Gene Ther 11: 619-627.
21. Blinkowa AL & Walker JR (1990) Programmed ribosomal frameshifting generates the Escherichia coli DNA polymerase III gamma subunit from within the tau subunit reading frame. Nucleic Acids Res 18: 1725-1729.
22. Bonetti B, Fu L, Moon J & Bedwell DM (1995) The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol 251: 334-345.
23. Brierley I & Dos Ramos FJ (2006) Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. Virus Res 119: 29-42.
24. Brierley I, Digard P & Inglis SC (1989) Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell 57: 537-547.
25. Brierley I, Rolley NJ, Jenner AJ & Inglis SC (1991) Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal. J Mol Biol 220: 889-902.
26. Brierley I, Gilbert RJ & Pennell S (2008) RNA pseudoknots and the regulation of protein synthesis. Biochem Soc T 36: 684-689.
27. Burke JF & Mogg AE (1985) Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res 13: 6265-6272.
28. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT & Ramakrishnan V (2000) Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407: 340-348.
29. Cassan M & Rousset JP (2001) UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. BMC Mol Biol 2: 3.
30. Cassan M, Delaunay N, Vaquero C & Rousset JP (1994) Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells. J Virol 68: 1501-1508.
31. Cheng Z, Saito K, Pisarev AV et al. (2009) Structural insights into eRF3 and stop codon recognition by eRF1. Genes Dev 23: 1106-1118.
32. Chung BY, Firth AE & Atkins JF (2010) Frameshifting in alphaviruses: a diversity of 3' stimulatory structures. J Mol Biol 397: 448-456.
33. Clark MB, Janicke M, Gottesbuhren U, Kleffmann T, Legge M, Poole ES & Tate WP (2007) Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues. J Biol Chem 282: 37359-37369.
34. Craigen WJ & Caskey CT (1986) Expression of peptide chain release factor 2 requires high-efficiency frameshift. Nature 322: 273-275.
35. Cui Y, Dinman JD & Peltz SW (1996) Mof4-1 is an allele of the UPF1/IFS2 gene which affects both mRNA turnover and -1 ribosomal frameshifting efficiency. EMBO J 15: 5726-5736.
36. Dinman JD & Wickner RB (1994) Translational maintenance of frame. Genetics 136: 75-86.
37. Dos Ramos F, Carrasco M, Doyle T & Brierley I (2004) Programmed -1 ribosomal frameshifting in the SARS coronavirus. Biochem Soc T 32: 1081-1083.
38. Dulude D, Baril M & Brakier-Gingras L (2002) Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1. Nucleic Acids Res 30: 5094-5102.
39. Eurwilaichitr L, Graves FM, Stansfield I & Tuite MF (1999) The C-terminus of eRF1 defines a functionally important domain for translation termination in Saccharomyces cerevisiae. Mol Microbiol 32: 485-496.
40. Fan-Minogue H & Bedwell DM (2008) Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA 14: 148-157.
41. Fearon K, McClendon V, Bonetti B & Bedwell DM (1994) Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family. J Biol Chem 269: 17802-17808.
42. Flanagan JF, Namy O, Brierley I & Gilbert RJ (2010) Direct observation of distinct A/P hybrid-state tRNAs in translocating ribosomes. Structure 18: 257-264.
43. Flower AM & McHenry CS (1990) The gamma subunit of DNA polymerase III holoenzyme of Escherichia coli is produced by ribosomal frameshifting. P Natl Acad Sci USA 87: 3713-3717.
44. Frolova L, Le Goff X, Rasmussen HH et al. (1994) A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature 372: 701-703.
45. Frolova L, Seit-Nebi A & Kisselev L (2002) Highly conserved NIKS tetrapeptide is functionally essential in eukaryotic translation termination factor eRF1. RNA 8: 129-136.
46. Gesteland RF & Atkins JF (1996) Recoding: dynamic reprogramming of translation. Annu Rev Biochem 65: 741-768.
47. Giedroc DP, Theimer CA & Nixon PL (2000) Structure, stability and function of RNA pseudoknots involved in stimulating ribosomal frameshifting. J Mol Biol 298: 167-185.
48. Girnary R, King L, Robinson L, Elston R & Brierley I (2007) Structure-function analysis of the ribosomal frameshifting signal of two human immunodeficiency virus type 1 isolates with increased resistance to viral protease inhibitors. J Gen Virol 88: 226-235.
49. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF & Atkins JF (1998) A dual-luciferase reporter system for studying recoding signals. RNA 4: 479-486.
50. Hainrichson M, Nudelman I & Baasov T (2008) Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases. Org Biomol Chem 6: 227-239.
51. Hansen JL, Ippolito JA, Ban N, Nissen P, Moore PB & Steitz TA (2002) The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol Cell 10: 117-128.
52. Harger JW & Dinman JD (2004) Evidence against a direct role for the Upf proteins in frameshifting or nonsense codon readthrough. RNA 10: 1721-1729.
53. Hung M, Patel P, Davis S & Green SR (1998) Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication. J Virol 72: 4819-4824.
54. Jacks T, Madhani HD, Masiarz FR & Varmus HE (1988) Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region. Cell 55: 447-458.
55. Kahlmeter G & Dahlager JI (1984) Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemoth 13 (suppl A): 9-22.
56. Kaufman RJ (1999) Correction of genetic disease by making sense from nonsense. J Clin Invest 104: 367-368.
57. Kaye JF & Lever AM (1996) Trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J Virol 70: 880-886.
58. Keeling KM & Bedwell DM (2002) Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med 80: 367-376.
59. Kollmus H, Honigman A, Panet A & Hauser H (1994) The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo. J Virol 68: 6087-6091.
60. Kontos H, Napthine S & Brierley I (2001) Ribosomal pausing at a frameshifter RNA pseudoknot is sensitive to reading phase but shows little correlation with frameshift efficiency. Mol Cell Biol 21: 8657-8670.
61. Kramer EB & Farabaugh PJ (2007) The frequency of translational misreading errors in E. coli is largely determined by tRNA competition. RNA 13: 87-96.
62. Lee SI, Umen JG & Varmus HE (1995) A genetic screen identifies cellular factors involved in retroviral -1 frameshifting. P Natl Acad Sci USA 92: 6587-6591.
63. Leger M, Dulude D, Steinberg SV & Brakier-Gingras L (2007) The three transfer RNAs occupying the A, P and E sites on the ribosome are involved in viral programmed -1 ribosomal frameshift. Nucleic Acids Res 35: 5581-5592.
64. Leinfelder W, Zehelein E, Mandrand-Berthelot MA & Bock A (1988) Gene for a novel tRNA species that accepts l-serine and cotranslationally inserts selenocysteine. Nature 331: 723-725.
65. Lopinski JD, Dinman JD & Bruenn JA (2000) Kinetics of ribosomal pausing during programmed -1 translational frameshifting. Mol Cell Biol 20: 1095-1103.
66. Manktelow E, Shigemoto K & Brierley I (2005) Characterization of the frameshift signal of Edr, a mammalian example of programmed -1 ribosomal frameshifting. Nucleic Acids Res 33: 1553-1563.
67. Manuvakhova M, Keeling K & Bedwell DM (2000) Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA 6: 1044-1055.
68. Marczinke B, Fisher R, Vidakovic M, Bloys AJ & Brierley I (1998) Secondary structure and mutational analysis of the ribosomal frameshift signal of rous sarcoma virus. J Mol Biol 284: 205-225.
69. Matsufuji S, Matsufuji T, Miyazaki Y, Murakami Y, Atkins JF, Gesteland RF & Hayashi S (1995) Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 80: 51-60.
70. Mazauric MH, Licznar P, Prere MF, Canal I & Fayet O (2008) Apical loop-internal loop RNA pseudoknots: a new type of stimulator of -1 translational frameshifting in bacteria. J Biol Chem 283: 20421-20432.
71. Mazauric MH, Seol Y, Yoshizawa S, Visscher K & Fourmy D (2009) Interaction of the HIV-1 frameshift signal with the ribosome. Nucleic Acids Res 37: 7654-7664.
72. Moran SJ, Flanagan JFt, Namy O, Stuart DI, Brierley I & Gilbert RJ (2008) The mechanics of translocation: a molecular 'spring-and-ratchet' system. Structure 16: 664-672.
73. Morris DK & Lundblad V (1997) Programmed translational frameshifting in a gene required for yeast telomere replication. Curr Biol 7: 969-976.
74. Namy O, Hatin I & Rousset JP (2001) Impact of the six nucleotides downstream of the stop codon on translation termination. EMBO Rep 2: 787-793.
75. Namy O, Duchateau-Nguyen G, Hatin I, Hermann-Le Denmat S, Termier M & Rousset JP (2003) Identification of stop codon readthrough genes in Saccharomyces cerevisiae. Nucleic Acids Res 31: 2289-2296.
76. Namy O, Rousset JP, Napthine S & Brierley I (2004) Reprogrammed genetic decoding in cellular gene expression. Mol Cell 13: 157-168.
77. Namy O, Moran SJ, Stuart DI, Gilbert RJ & Brierley I (2006) A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature 441: 244-247.
78. Namy O, Zhou Y, Gundllapalli S et al. (2007) Adding pyrrolysine to the Escherichia coli genetic code. FEBS Lett 581: 5282-5288.
79. Namy O, Galopier A, Martini C, Matsufuji S, Fabret C & Rousset JP (2008) Epigenetic control of polyamines by the prion [PSI(+)]. Nat Cell Biol 10: 1069-1075.
80. Napthine S, Liphardt J, Bloys A, Routledge S & Brierley I (1999) The role of RNA pseudoknot stem 1 length in the promotion of efficient -1 ribosomal frameshifting. J Mol Biol 288: 305-320.
81. Ortiz PA, Ulloque R, Kihara GK, Zheng H & Kinzy TG (2006) Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance. J Biol Chem 281: 32639-32648.
82. Palmer E, Wilhelm JM & Sherman F (1979) Variation of phenotypic suppression due to the psi+ and psi- extrachromosomal determinants in yeast. J Mol Biol 128: 107-110.
83. Pape T, Wintermeyer W & Rodnina MV (2000) Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. Nat Struct Biol 7: 104-107.
84. Peltz SW, Hammell AB, Cui Y, Yasenchak J, Puljanowski L & Dinman JD (1999) Ribosomal protein L3 mutants alter translational fidelity and promote rapid loss of the yeast killer virus. Mol Cell Biol 19: 384-391.
85. Peltz SW, Welch EM, Jacobson A, Trotta CR, Naryshkin N, Sweeney HL & Bedwell DM (2009) Nonsense suppression activity of PTC124 (ataluren). P Natl Acad Sci USA 106: E64; author reply E65.
86. Pennell S, Manktelow E, Flatt A, Kelly G, Smerdon SJ & Brierley I (2008) The stimulatory RNA of the Visna-Maedi retrovirus ribosomal frameshifting signal is an unusual pseudoknot with an interstem element. RNA 14: 1366-1377.
87. Plant EP & Dinman JD (2005) Torsional restraint: a new twist on frameshifting pseudoknots. Nucleic Acids Res 33: 1825-1833.
88. Plant EP, Jacobs KL, Harger JW et al. (2003) The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting. RNA 9: 168-174.
89. Plant EP, Wang P, Jacobs JL & Dinman JD (2004) A programmed -1 ribosomal frameshift signal can function as a cis-acting mRNA destabilizing element. Nucleic Acids Res 32: 784-790.
90. Politano L, Nigro G, Nigro V, Piluso G, Papparella S, Paciello O & Comi LI (2003) Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results. Acta Myol 22: 15-21.
91. Rosin-Arbesfeld R, Zilberberg A & Lahav L (2009) Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons. Gut 59: 496-507.
92. Rowe SM & Clancy JP (2009) Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs 23: 165-174.
93. Salas-Marco J & Bedwell DM (2004) GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination. Mol Cell Biol 24: 7769-7778.
94. Schmeing TM & Ramakrishnan V (2009) What recent ribosome structures have revealed about the mechanism of translation. Nature 461: 1234-1242.
95. Sermet-Gaudelus I, Renouil M, Fajac A et al. (2007) In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med 5: 5.
96. Shehu-Xhilaga M, Crowe SM & Mak J (2001) Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol 75: 1834-1841.
97. Shigemoto K, Brennan J, Walls E, Watson CJ, Stott D, Rigby PW & Reith AD (2001) Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res 29: 4079-4088.
98. Skuzeski JM, Nichols LM, Gesteland RF & Atkins JF (1991) The signal for a leaky UAG stop codon in several plant viruses includes the two downstream codons. J Mol Biol 218: 365-373.
99. Somogyi P, Jenner AJ, Brierley I & Inglis SC (1993) Ribosomal pausing during translation of an RNA pseudoknot. Mol Cell Biol 13: 6931-6940.
100. Song H, Mugnier P, Das AK et al. (2000) The crystal structure of human eukaryotic release factor eRF1 - mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell 100: 311-321.
101. Stahl G, Bidou L, Rousset JP & Cassan M (1995) Versatile vectors to study recoding: conservation of rules between yeast and mammalian cells. Nucleic Acids Res 23: 1557-1560.
102. Stansfield I, Jones KM, Kushnirov VV et al. (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14: 4365-4373.
103. Staple DW & Butcher SE (2003) Solution structure of the HIV-1 frameshift inducing stem-loop RNA. Nucleic Acids Res 31: 4326-4331.
104. Staple DW & Butcher SE (2005) Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element. J Mol Biol 349: 1011-1023.
105. Ter-Avanesyan MD, Kushnirov VV, Dagkesamanskaya AR, Didichenko SA, Chernoff YO, Inge-Vechtomov SG & Smirnov VN (1993) Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol 7: 683-692.
106. Toulme JJ, Di Primo C & Moreau S (2001) Modulation of RNA function by oligonucleotides recognizing RNA structure. Prog Nucleic Acid Re 69: 1-46.
107. Tribouillard D, Gug F, Galons H, Bach S, Saupe SJ & Blondel M (2007) Antiprion drugs as chemical tools to uncover mechanisms of prion propagation. Prion 1: 48-52.
108. Tsuchihashi Z & Kornberg A (1990) Translational frameshifting generates the gamma subunit of DNA polymerase III holoenzyme. P Natl Acad Sci USA 87: 2516-2520.
109. Vickers TA & Ecker DJ (1992) Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV gag-pol region. Nucleic Acids Res 20: 3945-3953.
110. Wagner KR, Hamed S, Hadley DW et al. (2001) Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49: 706-711.
111. Watts JM, Dang KK, Gorelick RJ et al. (2009) Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460: 711-716.
112. Weiss RB, Dunn DM, Atkins JF & Gesteland RF (1987) Slippery runs, shifty stops, backward steps, and forward hops: -2, -1, +1, +2, +5, and +6 ribosomal frameshifting. Cold Spring Harb Sym 52: 687-693.
113. Welch EM, Barton ER, Zhuo J et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447: 87-91.
114. Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264: 566-569.
115. Wilschanski M, Famini C, Blau H et al. (2000) A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Resp Crit Care 161: 860-865.
116. Wilson W, Braddock M, Adams SE, Rathjen PD, Kingsman SM & Kingsman AJ (1988) HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 55: 1159-1169.
117. Yuan J, O'Donoghue P, Ambrogelly A et al. (2010) Distinct genetic code expansion strategies for selenocysteine and pyrrolysine are reflected in different aminoacyl-tRNA formation systems. FEBS Lett 584: 342-349.
118. Zingman LV, Park S, Olson TM, Alekseev AE & Terzic A (2007) Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther 81: 99-103.